Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The impact of vildagliptin on the daily glucose profile and coronary plaque stability in impaired glucose tolerance patients with coronary artery disease: VOGUE-A multicenter randomized controlled trial.
Yamamoto H, Konishi A, Shinke T, Otake H, Kuroda M, Osue T, Sawada T, Takaya T, Kawai H, Hashimoto N, Ohara T, Hirota Y, Sakaguchi K, Omori T, Ogawa W, Hirata KI. Yamamoto H, et al. Among authors: kuroda m. BMC Cardiovasc Disord. 2021 Feb 15;21(1):92. doi: 10.1186/s12872-021-01902-0. BMC Cardiovasc Disord. 2021. PMID: 33588758 Free PMC article. Clinical Trial.
Impact of strut-vessel distance and underlying plaque type on the resolution of acute strut malapposition: serial optimal coherence tomography analysis after everolimus-eluting stent implantation.
Inoue T, Shinke T, Otake H, Nakagawa M, Hariki H, Osue T, Iwasaki M, Taniguchi Y, Nishio R, Hiranuma N, Konishi A, Kinutani H, Kuroda M, Hirata K. Inoue T, et al. Among authors: kuroda m. Int J Cardiovasc Imaging. 2014 Jun;30(5):857-65. doi: 10.1007/s10554-014-0422-z. Epub 2014 Apr 19. Int J Cardiovasc Imaging. 2014. PMID: 24748583
Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study.
Kuroda M, Shinke T, Sakaguchi K, Otake H, Takaya T, Hirota Y, Sugiyama D, Nakagawa M, Hariki H, Inoue T, Osue T, Taniguchi Y, Iwasaki M, Nishio R, Kinutani H, Konishi A, Hiranuma N, Takahashi H, Terashita D, Hirata KI. Kuroda M, et al. JACC Cardiovasc Interv. 2015 May;8(6):800-811. doi: 10.1016/j.jcin.2014.11.025. JACC Cardiovasc Interv. 2015. PMID: 25999102 Free article.
Association between daily glucose fluctuation and coronary plaque properties in patients receiving adequate lipid-lowering therapy assessed by continuous glucose monitoring and optical coherence tomography.
Kuroda M, Shinke T, Sakaguchi K, Otake H, Takaya T, Hirota Y, Osue T, Kinutani H, Konishi A, Takahashi H, Terashita D, Uzu K, Hirata K. Kuroda M, et al. Cardiovasc Diabetol. 2015 Jun 11;14:78. doi: 10.1186/s12933-015-0236-x. Cardiovasc Diabetol. 2015. PMID: 26062762 Free PMC article.
Effects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomography.
Kuroda M, Shinke T, Otake H, Sugiyama D, Takaya T, Takahashi H, Terashita D, Uzu K, Tahara N, Kashiwagi D, Kuroda K, Shinkura Y, Nagasawa Y, Sakaguchi K, Hirota Y, Ogawa W, Hirata K. Kuroda M, et al. Among authors: kuroda k. Cardiovasc Diabetol. 2016 May 21;15:79. doi: 10.1186/s12933-016-0395-4. Cardiovasc Diabetol. 2016. PMID: 27208906 Free PMC article.
The impact of serum trans fatty acids concentration on plaque vulnerability in patients with coronary artery disease: Assessment via optical coherence tomography.
Nagasawa Y, Shinke T, Toh R, Ishida T, Otake H, Takaya T, Sugiyama D, Toba T, Kuroda M, Takahashi H, Terashita D, Tahara N, Shinkura Y, Uzu K, Kashiwagi D, Kuroda K, Nagano Y, Yamamoto H, Yanaka K, Tsukiyama Y, Hirata KI. Nagasawa Y, et al. Among authors: kuroda k, kuroda m. Atherosclerosis. 2017 Oct;265:312-317. doi: 10.1016/j.atherosclerosis.2017.06.922. Epub 2017 Jun 28. Atherosclerosis. 2017. PMID: 28697847 Free article.
Impact of CD14++CD16+ monocytes on plaque vulnerability in diabetic and non-diabetic patients with asymptomatic coronary artery disease: a cross-sectional study.
Yoshida N, Yamamoto H, Shinke T, Otake H, Kuroda M, Terashita D, Takahashi H, Sakaguchi K, Hirota Y, Emoto T, Amin HZ, Mizoguchi T, Hayashi T, Sasaki N, Yamashita T, Ogawa W, Hirata KI. Yoshida N, et al. Among authors: kuroda m. Cardiovasc Diabetol. 2017 Aug 8;16(1):96. doi: 10.1186/s12933-017-0577-8. Cardiovasc Diabetol. 2017. PMID: 28789689 Free PMC article.
Impact of CD14++CD16+ monocytes on coronary plaque vulnerability assessed by optical coherence tomography in coronary artery disease patients.
Yamamoto H, Yoshida N, Shinke T, Otake H, Kuroda M, Sakaguchi K, Hirota Y, Toba T, Takahashi H, Terashita D, Uzu K, Tahara N, Shinkura Y, Kuroda K, Nagasawa Y, Nagano Y, Tsukiyama Y, Yanaka KI, Emoto T, Sasaki N, Yamashita T, Ogawa W, Hirata KI. Yamamoto H, et al. Among authors: kuroda k, kuroda m. Atherosclerosis. 2018 Feb;269:245-251. doi: 10.1016/j.atherosclerosis.2018.01.010. Epub 2018 Jan 17. Atherosclerosis. 2018. PMID: 29407600
Impact of daily glucose fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease undergoing lipid-lowering therapy.
Yamamoto H, Shinke T, Otake H, Kawamori H, Toba T, Kuroda M, Hirota Y, Sakaguchi K, Ogawa W, Hirata KI. Yamamoto H, et al. Among authors: kuroda m. J Diabetes Investig. 2021 Jun;12(6):1015-1024. doi: 10.1111/jdi.13448. Epub 2020 Dec 18. J Diabetes Investig. 2021. PMID: 33098191 Free PMC article.
2,296 results